Home › Cases › Heart Failure with Preserved EF (HFpEF)
Acute Heart Failure
Heart Failure with Preserved EF (HFpEF)
6 questions
Question 1 · HFpEF vs HFrEF
Correct answer: Heart failure with preserved ejection fraction (HFpEF) — EF ≥50%, symptoms of HF, BNP elevated, diastolic dysfunction
Why
HFpEF: symptoms of heart failure + preserved EF (≥50%) + elevated BNP + diastolic dysfunction (impaired relaxation, elevated filling pressures). Accounts for around 50% of heart failure. Risk factors: hypertension (most common), diabetes, obesity, AF. Prognosis remains poor; mortality varies, and HF admissions can be as frequent as in HFrEF.
Key point
HFpEF: HF symptoms + EF ≥50% + elevated BNP + diastolic dysfunction. Around 50% of HF. Hypertension is main cause.
Question 2 · HFpEF treatment
Correct answer: SGLT2 inhibitors (dapagliflozin/empagliflozin) now have evidence for HFpEF. Consider an MRA too. Diuretics for symptoms. BP control. Weight loss. Treat AF
Why
HFpEF treatment: EMPEROR-Preserved and DELIVER trials: SGLT2 inhibitors (empagliflozin/dapagliflozin) reduce HF hospitalisation in HFpEF and HFmrEF. Diuretics for fluid symptoms. Control BP, AF, obesity, diabetes. Consider an MRA alongside an SGLT2 inhibitor; check renal function and potassium. Benefit is not limited to mortality: reducing HF admissions matters.
Key point
HFpEF: SGLT2 inhibitors reduce hospitalisation (EMPEROR-Preserved/DELIVER). Consider an MRA; diuretics for congestion. Control comorbidities.
Question 3 · BNP interpretation
Correct answer: BNP elevated by: AF, PE, CKD, sepsis, RV failure, obesity falsely lowers BNP. Interpret in clinical context
Why
BNP can rise with AF, PE, pulmonary hypertension, CKD (reduced clearance), sepsis and acute MI.
- Natriuretic peptide levels can be lower with obesity, African/African-Caribbean ethnic background and HF treatment (diuretics, ACEi/ARB/ARNI, beta-blockers, MRAs).
- NICE outpatient suspected chronic HF thresholds use NT-proBNP, not BNP: >2000ng/L → specialist assessment/echo within 2 weeks; 400–2000ng/L → within 6 weeks; <400ng/L in an untreated person → HF less likely.
- If concern persists despite NT-proBNP <400, discuss with a heart-failure specialist.
Key point
BNP elevated by: AF, PE, CKD, sepsis. Obesity falsely lowers BNP. Interpret in context. NT-proBNP thresholds differ.
Question 4 · Diastolic dysfunction grading
Correct answer: Pseudonormal filling — impaired relaxation + reduced compliance. Appears normal but is elevated filling pressures disguised by increased LA pressure
Why
- Grade1: impaired relaxation, usually normal resting left-atrial pressure
- Grade2: pseudonormal filling with raised pressure
- Grade3: restrictive filling with markedly raised pressure
Do not grade from E/e′ alone. Use mitral E/A, annular e′, E/e′ and other echo measures. Once elevated pressure is established, E/A<2 favours grade 2; ≥2 grade 3, using the appropriate rhythm/valve-specific algorithm.
Key point
Diastolic dysfunction: Grade 1 (impaired relaxation) → Grade 2 (pseudonormal) → Grade 3 (restrictive, worst prognosis).
Question 5 · Diuretic use in HFpEF
Correct answer: Loop diuretic titrated to symptoms — start low, increase carefully. HFpEF patients preload-sensitive, over-diuresis worsens output
Why
Diuretics in HFpEF: use carefully — HFpEF patients are very preload sensitive (stiff ventricle needs higher filling pressure). Over-diuresis → reduced stroke volume → hypotension. Furosemide 20–40mg starting dose. Titrate symptomatically. Monitor renal function. Aim: relief of congestion symptoms without hypotension.
Key point
HFpEF diuretics: careful titration. Preload-sensitive — over-diuresis causes hypotension. Start low, titrate symptoms.
Question 6 · AF in HFpEF
Correct answer: Rate control with a beta-blocker or digoxin, specialist rhythm-control discussion and anticoagulation after bleeding-risk assessment
Why
For stable AF, an initial resting HR<110bpm is often reasonable; aim lower if symptoms persist. Use a beta-blocker or digoxin as appropriate; digoxin has a narrow therapeutic index. EAST-AFNET 4 supports early rhythm control in selected recently diagnosed AF. Assess stroke and bleeding risk: Mrs Hill’s age and HF qualify her for anticoagulation, but HF alone is not a universal indication regardless of score.
Key point
Rate control, consider early rhythm control, assess stroke risk. HR<110 is an initial target; tighten for persistent symptoms. Anticoagulate Mrs Hill after bleeding-risk assessment.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.